The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia.
about
Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumabPeripheral T-Cell lymphoma manifested as gingival enlargement in a patient with chronic lymphocytic leukemiamiR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation.The clinical and epidemiological burden of chronic lymphocytic leukaemia.Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemiaCutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.Practical approach to management of chronic lymphocytic leukemiaTreating recurrent cases of squamous cell carcinoma with radiotherapyIdelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomasImpact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.Validation of a new prognostic index for patients with chronic lymphocytic leukemia.Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden.Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia.County level incidence rates of chronic lymphocytic leukemia are associated with residential radon levels.Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria.Obinutuzumab (GA101) is highly effective against chronic lymphocytic leukemia cells in ex vivo B-cell depletion irrespective of high-risk prognostic markers.Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.
P2860
Q30833823-77D32017-342D-4F60-B3C3-C54C24CA425BQ34184717-AE63E9F5-0870-4BBF-A663-FBDFC4ECC36AQ34974058-28026D60-C9CA-42A1-A3A9-9128AEB49CA7Q35076449-5EA7F788-DEF8-4726-84D2-710E8BDF61CDQ35098517-F4B50DD4-0134-47C1-94A2-66F34D17A5B2Q35176071-5CEDCE2D-28D7-4A57-AA06-BC1F109D879FQ35804467-9F4CD6C7-194D-40B7-85B8-BC5BE4DB86E4Q35848136-BF1AE9AB-C8F0-4A93-8043-B20022AA059DQ36311279-06262B35-3F33-4891-B899-E606FB6C475DQ36845277-40C8E427-CB82-4A04-8444-0BA6A3D47D34Q36971733-DAD0E759-917F-439B-AFC9-300588C03347Q37058203-B47EABFB-7548-42B2-A783-4C1F84C84072Q37065666-83B5702E-1804-4E4A-BB5B-2A9AF6288DE2Q37068125-A6E8F1FC-6473-480E-A162-1C87E7E72ABDQ37334960-1EA5AD74-394C-4F61-9A42-897FF9F787B7Q37387647-D8C3C09D-F642-446A-B763-B798A219EB42Q37517126-9493286A-D11F-4224-BFCE-D60A0139B8E2Q37517160-D530766D-957A-4DF9-B4E2-29548823D033Q38611435-703B1E1D-2A5A-4C35-B634-183E2DA2BEF4Q40156239-4F984D46-4AC7-4413-AC48-BA1F88027344Q42643066-3FC4EDF3-F226-4890-A6CB-76C12DE44F2DQ51001351-E9AAD31C-A851-415B-8B75-AF8475EFA5BDQ53174983-B344A5F6-936E-48DB-9CBD-0C990D2E9D8B
P2860
The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The American College of Surgeo ...... chronic lymphocytic leukemia.
@ast
The American College of Surgeo ...... chronic lymphocytic leukemia.
@en
type
label
The American College of Surgeo ...... chronic lymphocytic leukemia.
@ast
The American College of Surgeo ...... chronic lymphocytic leukemia.
@en
prefLabel
The American College of Surgeo ...... chronic lymphocytic leukemia.
@ast
The American College of Surgeo ...... chronic lymphocytic leukemia.
@en
P2093
P1433
P1476
The American College of Surgeo ...... chronic lymphocytic leukemia.
@en
P2093
P304
P356
10.1002/(SICI)1097-0142(19991215)86:12<2684::AID-CNCR13>3.3.CO;2-M
P407
P577
1999-12-01T00:00:00Z